In 13 patients with grade III or grade IV hypertensive retinopathy the effect of intramuscular hexamethonium bromide on cerebral circulation and metabolism has been studied. The results have been compared with Dewar's study of hexamethonium in less severe hypertensive patients and with Kety's results following differential spinal sympathetic block. Sixty minutes after intramuscular hexamethonium, mean arterial blood pressure fell 39 per cent, cerebral vascular resistance was reduced 29 per cent, and cerebral blood flow decreased 16 per cent. Cerebral oxygen consumption was maintained at the expense of a reduction in cerebral venous oxygen saturation. HE EFFECT of hexamethonium upon blood flow in various organs of hypertensive patients has been reported by several investigators. Cardiac output was reduced in compensated patients.' Renal blood flow decreased initially but returned to control value despite a continued reduction in arterial blood pressure.' 2 Blood flow through the abdominal viscera decreased in proportion to the fall in arterial blood pressure.3 The present report concerns the effect of hexamethonium upon cerebral hemodynamics and metabolism in 13 patients with severe hypertension.
In 13 patients with grade III or grade IV hypertensive retinopathy the effect of intramuscular hexamethonium bromide on cerebral circulation and metabolism has been studied. The results have been compared with Dewar's study of hexamethonium in less severe hypertensive patients and with Kety's results following differential spinal sympathetic block. Sixty minutes after intramuscular hexamethonium, mean arterial blood pressure fell 39 per cent, cerebral vascular resistance was reduced 29 per cent, and cerebral blood flow decreased 16 per cent. Cerebral oxygen consumption was maintained at the expense of a reduction in cerebral venous oxygen saturation. HE EFFECT of hexamethonium upon blood flow in various organs of hypertensive patients has been reported by several investigators. Cardiac output was reduced in compensated patients.' Renal blood flow decreased initially but returned to control value despite a continued reduction in arterial blood pressure.' 2 Blood flow through the abdominal viscera decreased in proportion to the fall in arterial blood pressure.3 The present report concerns the effect of hexamethonium upon cerebral hemodynamics and metabolism in 13 patients with severe hypertension.
METHOD Thirteen hospitalized patients with premalignant or malignant hypertension were studied in the supine position. Ages ranged from 28 to 48 years. Six 106 was demonstrated by standard clinical tests, but blood nonprotein nitrogen value was within the normal range. In four of the patients a cerebral vascular hemorrhage had occurred six months to one year prior to the present study. Cardiac functional capacity was I-II. None of the group had previously received hexamethonium.
Control measurements were made, and hexamethonium was administered intramuscularly (mean average dose 1.0 mg. per kilogram). Mean arterial blood pressure fell within 5 to 30 minutes. The second blood flow determination was made 60 minutes after drug injection, at which time the blood pressure had stabilized. Cerebral blood flow (CBF) was determined by the nitrous oxide method of Kety and Schmidt.4 Mean arterial blood pressure (MABP) was obtained directly by a needle in the femoral artery attached to a Statham strain gage or damped mercury manometer. Blood gas analyses for oxygen, carbon dioxide, and nitrous oxide were made with the Van Slyke-Neill manometric apparatus. Venous oxygen saturation was determined by Venous oxygen content. Hemoglobin X 1.34 Cerebral oxygen consumption (CMRO2) and cerebrovascular resistance (CVR) were calculated as previously described.4
RESULTS
The results are presented in tables 1 and 2. Mean arterial blood pressure fell from 181 to 111 mm. Hg, representing a decrease of 39 per cent. Cerebral vascular resistance was reduced 29 per cent. Cerebral blood flow fell from 55 to 46 cc. per 100 Gm. per minute (16 per cent). These changes were significant Circulation, Volume XI, January, 1955 Fundi   III  III  IV  III  III  IV  IV  IV  III   IV  IV   IV (p < 0.01). Cerebral oxygen consumption did not change significantly in spite of the reduced blood flow through the brain. This was maintained at the expense of a reduction in cerebral venous oxygen saturation. Such a reduction indicates a decrease in the ability Decrease in internal jugular oxygen saturation plotted against decrease in mean arterial pressure following hexamethonium. The horizontal line at zero represents no change in cerebral venous oxygen saturation. Open circles represent the actual reduction in oxygen saturation of internal jugular venous blood for each patient following hexamethonium. circles denote values calculated on the basis of no change in cerebrovascular resistance. There was not a sufficient number of values to justify calculating a statistical curve of regression, but the figure suggests that a majority of our patients exhibited a progressive decrease in cerebral venous oxygen saturation as the mean arterial blood pressure fell. However the change in cerebral venous oxygen saturation was not as severe as would have occurred without a significant cerebrovascular relaxation.
Solid circles denote values calculated on the basis
Other significant metabolic changes included a decrease in arterial oxygen content and a rise in cerebral venous carbon dioxide content following hexamethonium.
DISCUSSION
Cerebral blood flow and cerebral oxygen consumption were observed to be within the normal range in 13 patients with premalignant or malignant hypertension. There was a marked and consistent inicrease in cerebrovascular resistance averaging 119 per cent, which appeared to be roughly correlated with the grade of retinopathy.
These studies indicate that the reduction in cerebral vascular resistance, although significant, was not sufficient to compensate completely for the fall in blood pressure following hexamethonium. Some information regarding the possible mechanism of the reduction in cerebrovascular resistance in hypertensive patients following hexamethonium may be obtained by comparing our results and those of Dewar5 with those of Kety6 following differential spinal block. Kety observed a 16 per cent reduction in cerebral vascular resistance following a decrease in blood pressure brought about by a procedure which acted on vascular beds remote from the brain. We observed a 29 per cent and Dewar a 28 per cent reduction in cerebrovascular resistance following parenteral hexamethonium. The blood pressure reductions reported by Kety and by Dewar were of comparable magnitude, while that observed by us was of greater severity.
In each of these studies the arterial blood pressure was lowered to approximately the same level. It would then appear that hexa-methonium is more effective than differential spinal block in reducing resistance to blood flow through the brain in hypertensive patients. This could be the result of (1) blocking of the autonomic innervation of the cerebral blood vessels, (2) a more profound change in cerebral metabolites, and (3) a direct action on the smooth muscle of the cerebral vessels.
Most of the experimental evidence indicates that the cerebral sympathetics play a minor role in the regulation of cerebral vascular resistance in hypertensive patients which would tend to discredit the first possibility.7 Since the changes in cerebral venous oxygen and carbon dioxide were comparable in both the differential spinal block and our hexamethonium studies, this would hardly account for the difference observed in the cerebral vascular resistance. It seems, therefore, that the most likely explanation is a direct action of hexamethonium on cerebral blood vessels.
Dewar observed essentially no change in cerebral blood flow following hexamethonium in six hypertensive patients. Five of his patients had grade II and one had grade IV hypertensive retinopathy. Administration of hexamethonium resulted in a reduction in mean arterial blood pressure from 153 to 107 mm. Hg (30 per cent). All of the patients in our series had either grade III or grade IV hypertensive retinopathy. Following hexamethonium there was a 39 per cent reduction in mean arterial blood pressure and a 16 per cent decrease in cerebral blood flow. In both studies the cerebral vascular resistance was reduced by approximately 30 per cent. Therefore, in our patients the cerebral blood vessels were incapable of relaxing to a degree sufficient to maintain normal cerebral blood flow in contrast to Dewar's observations. It seems likely that the severity of the hypertensive vascular disease could account for the reduction in cerebral blood flow. These studies seem to indicate that the mean arterial blood pressure should not be acutely reduced with hexamethonium by more than 30 per cent of the control value in patients with premalignant or malignant hypertensive vascular disease.
Morris8 reported a 39 per cent reduction in mean arterial blood pressure in normotenisive patients following hexamethonium infusion. He observed a 30 per cent decrease ill cerebral blood flow compared with our 16 per cent change from the control value. However in his patients the cerebral arterial perfusion pressure following hexamethonium was 62 mm. Hg. This degree of hypotension probably accounts for the differences in our results.
The slight increase in blood volume, due predominantly to an increase in plasma volume observed by Morris following hexamethonium, might play a role ill lowering the arterial oxygen content. SUMMARY 1. The effect of hexamethonium bromide upon cerebral hemodynamics and metabolism was studied in 13 patients with severe hypertension.
2. Sixty minutes after intramuscular hexamethonium mean arterial blood pressure fell 39 per cent, cerebral vascular resistance was reduced 29 per cent, and cerebral blood flow decreased 16 per cent.
3. Cerebral oxygen consumption was maintained at the expense of a reduction in cerebral venous oxygen saturation.
4. The possible mechanisms of action of hexamethonium upon the cerebral vascular bed are discussed. 5 . These studies, in conjunction with the observations of Dewar, seem to indicate that the mean arterial blood pressure should niot be acutely reduced with hexamethonium by more than 30 per cent of the control value in patients with either premalignant or malignant hypertensive vascular disease. SUMMARIO IIN INTERLINGUA 1. Le effecto de bromido de hexamethonium super le hemodynamica e metabolismo cerebral esseva studiate ill 13 patientes con sever hypertension.
2. Sexanta minutas post le administration intramuscular de hexamethonium le valores median del pression arterial cadeva per 39 pro cento; le resistentia vascular in le cerebro esseva reducite per 29 pro cento; e le fluxo sanguinee in le cerebro suffreva un reduction de 16 pro cento.
3. Le consumption cerebral de oxygeno esseva mantenite al costo de un reduction del saturation cerebro-venal de oxygeno. 4 . Le possibile mechanismo del action de hexamethonium super le base vascular del cerebro es discutite. 5. Iste studios--conjunctemente con le observationes de Dewar--pare indicar que in patientes con morbo vascular hypertensive in phases premaligne o maligne le valores median del pression arterial non deberea esser reducite acutemente per plus que 30 pro cento del valores de controlo.
